An epigenetics study on non-alcoholic steatohepatitis (NASH) found hypomethylation of the ACSL4 gene in peripheral blood lymphocytes, leading to its overexpression and suggesting its potential as a biomarker for NASH-associated ferroptosis. This evidence concerns the gene ACSL4 and metabolic dysfunction-associated steatohepatitis.